When tested for their activity in suppressing the acquisition of immunity during acute Besnoitia infection of hamsters, antilymphocyte serum (ALS), aminopterin, cyclophosphamide, cortisol, and whole-body irradiation were the most active agents and effectively blocked the development of immunity during 4 to 12 days of immunization. Actinomycin D and chlorambucil were moderately active, and nitrogen mustard, 6-mercaptopurine, and vinblastine exhibited slight immunosuppressive activity. Established immunity was especially labile to cortisol and cortisone administration with generalized Besnoitia relapse occurring consistently in all hamsters; this occurred infrequently during cyclophosphamide treatment. Focal relapse was seen in chronically irradiated and ALS-treated hamsters, but the location of the lesions differed. Irradiated hamsters had lesions in the lungs and brain, whereas ALS-treated hamsters showed splenic relapse. Acquisition of immunity was more sensitive to suppression than established immunity and did not necessarily parallel antibody development and vice versa, emphasizing the importance of cellular over humoral factors in immunity to this intracellular parasite.
Besnoitia jellisoni is an obligate intracellular protozoan parasite resembling Toxoplasma both in its morphology and pathogenic effects in the hamster (2) . Utilizing therapeutic control of infection, specific immunity to Besnoitia is developed which can be transferred by cells from immune donors (6) .
Corticoid administration delays the immunization process, curtails the ability of cells from immune donors to transfer immunity, and suppresses established immunity to a degree that generalized, fatal Besnoitia relapse occurs consistently (4, 9) . The effects of irradiation on acquisition and transfer of immunity are similar to those of corticoids; however, established immunity is quite resistant to radiation (J. K. Frenkel and H. R. Wilson, J. Infec. Dis., in press). Such difference in action suggested that studies utilizing other potentially immunosuppressive agents might contribute to the characterization of the cells involved in this specific cellular immunity.
MATERIALS AND METHODS
Hosts. Female LVG/LAK golden hamsters, 6 weeks of age or older, obtained from Lakeview Hamster Colony, Newfield, N. J., were used in all experiments. jellisoni obtained from pooled mouse ascitic fluid as described previously (6) .
Immunization experiments. Prophylactic treatment with sulfadiazine inhibits multiplication of Besnoitia, and the degree of immunity acquired increases with duration of therapy during the first 2 weeks of infection (9) . Thus, various degrees of immunity were developed in the two immunization experiments by giving hamsters 90 mg of sodium sulfadiazine per 100 ml in their drinking water for 3, 7, or 11 days beginning the day after infection.
Treatment with potentially immunosuppressive agents was initiated 24 hr before infection and continued through day 20 except as indicated. Cortisol as the free alcohol was used as a known immunosuppressive agent (9) .
Chronic infection with immunity. Chronic Besnoitia infection was produced by infecting hamsters and treating them with sodium sulfadiazine as above from day 1 to day 14; they were then challenged subcutaneously with live Besnoitia on day 28. Their immune status was verified by the capacity to survive a subcutaneous challenge of 106 organisms, usually without developing a lesion at the injection site. Since immunity to Besnoitia is of the premunition type (4, 9), hamsters surviving the challenge infection were considered to be both immune and chronically infected.
Potentially immunosuppressive agents were administered, utilizing relapse as an indicator of their potency in comparison with cortisol alcohol. 756
IMMUNOSUPPRESSION IN INTRACELLULAR INFECTION
Autopsy procedure and findings. Complete autopsies were performed on hamsters which died in these experiments to determine the probable causes of death, in particular to differentiate between Besnoitiarelated deaths and those due to direct toxic effect of some of the drugs used. Data were obtained from gross findings, lung impression smears, and histological study of all organs. Impression smears were stained with Giemsa. Organs were fixed in Zenker-Formalin solution (Helly's fluid), and sections were stained with Giemsa. Bacterial cultures were made on bloodagar plates when gross findings at death were not typical of besnoitiosis.
The lesions resulting from acute Besnoitia infection in subcutaneously inoculated hamsters include: pneumonia, meningoencephalitis, and variable degrees of infection-necrosis in the adrenals, liver, spleen, lymph nodes, thymus, bone marrow, or fat.
Typical lesions of relapse included pneumonia and encephalitis, occasionally with lesions in several organs, all a result of the reactivated Besnoitia infection.
Immunosuppressive agents. All cytotoxic drugs were given at near-lethal levels as determined in preliminary chronic administration tests: the dose of a drug was doubled biweekly; the last dose before that which caused drug-related death was used.
(i) Actinomycin D (Cosmegen; Merck Sharp and Dohme) was reconstituted and diluted with sterile distilled water to 0.020 mg/ml; samples were kept frozen at -20 C; 6.0 ,ug was injected intraperitoneally six times per week.
(ii) Aminopterin sodium (Lederle) tablets were crushed and suspended in 10% gum acacia before use; 100 ,ug was given by stomach tube six times per week.
(iii) Antilymphocyte serum was produced in a rabbit by injection of LVG/LAK hamster thoracic duct lymphocytes. Initially, 5 (29) for Toxoplasma antibody, essentially as outlined by Frenkel and Jacobs (8) . In these experiments, Besnoitia organisms were used instead of Toxoplasma, and citrated plasma was used as accessory factor according to the procedure of Wallace (32) .
RESULTS
Acquisition of immunity. Sufficient immunity developed in the nonimmunosuppressed hamsters during 8 days of sulfadiazine control of infection to permit indefinite survival ( Table 1 , Fig. 1 ). However, most immunosuppressive agents impaired the acquisition of immunity so severely that many hamsters eventually died of Besnoitia infection, even after 12 days of sulfadiazine control of infection. Thus, hamsters treated with irradiation, with aminopterin, and, in experiment 1, with cortisol alcohol died of acute Besnoitia infection 7 to 8 days after cessation of sulfadiazine therapy. In contrast, the time to death after discontinuing sulfadiazine therapy was considerably delayed in the actinomycinand especially the chlorambucil-treated hamsters, demonstrating that, although some immunity was acquired in the case of the latter two drugs, it was insufficient to prevent the eventual death of the hamster. Antilymphocyte serum, which Hamsters treated with antilymphocyte serum developed a septic peritonitis and probably died from its sequelae. However, at death, areas of splenic necrosis with multiplying Besnoitia located peripherally were observed in all animals; no other significant lesions attributable to Besnoitia were found in these hamsters.
None of the other immunosuppressive treatments employed in immunization experiments produced relapse of Besnoitia infection, even when the treatments were administered at levels which eventually caused death of the hamsters. DISCUSSION Survival of a Besnoitia-infected hamster after withdrawal of sulfadiazine therapy is a measure of immunity to this infection (2, 4, 9) . With this criterion, all agents examined inhibited the acquisition of immunity during primary Besnoitia infection to some degree. Aminopterin, cortisol, and irradiation were the most active, and most hamsters treated with these agents died of acute besnoitiosis soon after sulfadiazine was discontinued. Antilymphocyte serum was also as active as the above agents in the initial stages of infection; the reasons for the decrease in activity after 12 days of immunization are not clear. Although a foreign protein and presumably antigenic, formation of antibodies to antilymphocyte serum in the recipient animal does not necessarily mean diminution of antilymphocyte serum activity (24) .
Considering established immunity, however, only cortisol or cortisone regularly provoked generalized Besnoitia relapse, as has been found after administration of other corticosteroid preparations (4) . Established immunity to latent infections appears particularly labile to exogenous hypercorticism. As in chronic besnoitiosis, relapse as a result of corticoid-induced immunosuppression has been demonstrated in toxoplasmosis (1-3), pneumocystosis (7, 26, 27) , several fungal infections (5), tuberculosis (14) , cytomegalovirus infection (17) , and varicella infection (25) . Wilson, J. Infec. Dis., in press) and preventing the development of immunity in Besnoitia-infected hamsters. In contrast, irradiated, lymphocytic choriomeningitis virus-infected mice show less disease than unirradiated controls (28) . In the latter case, tissue injury is related to a hypersensitivity response which irradiation diminishes (23), whereas an intact immune system is necessary for survival in besnoitiosis.
Finally, antilymphocyte serum has been found to be particularly effective in inhibiting the development of a variety of cellular immunities ranging from those involved with transplantation rejection to those involved with infectious diseases (12, 20, 22) . With respect to infections, administration of antilymphocyte serum has been foltnd to diminish the cellular immune response to viruses (13, 31) , bacteria (10, 11, 21) , and a nematode infection (18) . The effect of antilymphocyte serum on antibody production is not as well agreed on (15, 19) ; this effect appears to be influenced even by the strain of animal involved (16) , again emphasizing the need for careful analysis of discrepant findings before general interpretation.
The present studies demonstrate that acquisition of immunity to Besnoitia is much more vulnerable to a variety of immunosuppressive agents than established immunity. The cellular nature of anti-Besnoitia immunity in hamsters (6; J. K. Frenkel and H. R. Wilson, J. Infec. Dis., in press) was reaffirmed from the effects of cortisol and irradiation on immunity, but not antibody production, and the reverse situation in 6-mercaptopurine-treated animals. Detailed studies are in progress to apply these findings to the identification of the cells involved in cellular immunity.
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